Clinical trials
Metabolic Diseases trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 4 |
| 2021 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| AO GENERIUM | 3 |
| Eli Lilly and Company | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| National Medical Research Center for Therapy and Preventive Medicine | 1 |
| Novartis Pharmaceuticals | 1 |
| POLYSAN Scientific & Technological Pharmaceutical Company | 1 |
| Rezolute | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 15 |
| Diabetes Mellitus, Type 2 | 8 |
| Glucose Metabolism Disorders | 7 |
| Diabetes Mellitus | 6 |
| Endocrine System Diseases | 5 |
| Genetic Diseases, Inborn | 4 |
| Lysosomal Storage Diseases | 4 |
| Genetic Diseases, X-Linked | 3 |
| Mucopolysaccharidosis II | 3 |
| Neurobehavioral Manifestations | 3 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.